Provided by Tiger Fintech (Singapore) Pte. Ltd.

TG Therapeutics

43.44
-1.9300-4.25%
Post-market: 43.600.1625+0.37%19:56 EDT
Volume:4.17M
Turnover:184.69M
Market Cap:6.90B
PE:289.60
High:45.97
Open:45.37
Low:42.96
Close:45.37
Loading ...
Aug 06, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 02, 2021

Major Issues Report

8-K - Current report
Jun 23, 2021

Major Issues Report

8-K - Current report
Jun 21, 2021

Major Issues Report

8-K - Current report
May 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 10, 2021

Major Issues Report

8-K - Current report
Apr 16, 2021

Major Issues Report

8-K - Current report
Apr 13, 2021

Major Issues Report

8-K - Current report
Mar 02, 2021

Major Issues Report

8-K - Current report
Mar 01, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2021

Major Issues Report

8-K - Current report
Feb 01, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 16, 2020

Major Issues Report

8-K - Current report
Dec 10, 2020

Major Issues Report

8-K - Current report
Dec 08, 2020

Major Issues Report

8-K - Current report